We are live on ! Find out more
VIM

Veritas Investment Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 25.54%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+25.54%
3 Year Est. Return
+69.01%
5 Year Est. Return
+144.34%
10 Year Est. Return
AUM
$566M
AUM Growth
+$32.8M
Cap. Flow
+$18.7M
Cap. Flow %
3.31%
Top 10 Hldgs %
84.18%
Holding
83
New
10
Increased
11
Reduced
19
Closed
6

Top Sells

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$7.87M
2
ORCL icon
Oracle
ORCL
+$3.41M
3
MSFT icon
Microsoft
MSFT
+$1.4M
4
UNH icon
UnitedHealth
UNH
+$839K
5
VAR
Varian Medical Systems, Inc.
VAR
+$831K

Sector Composition

Rank Sector Weight
1 Healthcare 34.19%
2 Technology 25.24%
3 Communication Services 21.15%
4 Financials 17.11%
5 Consumer Staples 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$67.3M 11.9%
1,082,832
-23,229
-2% -$1.4M
UNH icon
2
UnitedHealth
UNH
$382B
$66.4M 11.75%
414,918
-5,617
-1% -$839K
CMCSA icon
3
Comcast
CMCSA
$87.3B
$58.8M 10.4%
1,701,026
+54,554
+3% +$1.82M
TMO icon
4
Thermo Fisher Scientific
TMO
$214B
$51.8M 9.15%
366,722
+153,199
+72% +$22.6M
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.1T
$45M 7.96%
276,174
+14,629
+6% +$2.25M
CVS icon
6
CVS Health
CVS
$135B
$44M 7.78%
557,291
+37,125
+7% +$3M
MA icon
7
Mastercard
MA
$498B
$40.7M 7.19%
393,617
+28,637
+8% +$2.96M
CTSH icon
8
Cognizant
CTSH
$25.2B
$35.9M 6.35%
641,097
-147,040
-19% -$7.87M
ORCL icon
9
Oracle
ORCL
$339B
$34.2M 6.04%
888,995
-87,085
-9% -$3.41M
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.12T
$32.1M 5.67%
809,220
+17,240
+2% +$689K
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.11T
$26.7M 4.72%
691,580
+38,860
+6% +$1.51M
WAT icon
12
Waters Corp
WAT
$37.3B
$18.8M 3.33%
139,922
-3,725
-3% -$532K
LH icon
13
Labcorp
LH
$25.2B
$10.4M 1.83%
94,054
+2,179
+2% +$242K
MO icon
14
Altria Group
MO
$125B
$5M 0.88%
73,900
-275
-0.4% -$17.7K
NTRS icon
15
Northern Trust
NTRS
$21.8B
$4.67M 0.83%
52,500
-2,000
-4% -$159K
MCO icon
16
Moody's
MCO
$83.7B
$2.01M 0.36%
21,355
+700
+3% +$70.7K
MRSH
17
Marsh
MRSH
$94.3B
$1.91M 0.34%
28,200
FISV
18
Fiserv Inc
FISV
$29.7B
$1.66M 0.29%
31,200
PAYX icon
19
Paychex
PAYX
$43.4B
$1.46M 0.26%
23,909
DIS icon
20
Walt Disney
DIS
$171B
$961K 0.17%
9,215
+190
+2% +$18.5K
VZ icon
21
Verizon
VZ
$197B
$890K 0.16%
16,674
-412
-2% -$20.6K
BNY
22
Bank of New York Mellon
BNY
$103B
$866K 0.15%
18,280
HSY icon
23
Hershey
HSY
$37.3B
$763K 0.13%
7,378
RTX icon
24
RTX Corp
RTX
$290B
$727K 0.13%
10,527
ALGN icon
25
Align Technology
ALGN
$12.9B
$725K 0.13%
7,538
-100
-1% -$9.29K

Similar funds

Veritas Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Veritas Investment Management held 83 positions worth $566M, up 6.2% from $533M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Veritas Investment Management deployed $18.7M of net new capital in Q4 2016, opening 10 new positions and adding to 11 existing holdings. Its largest new stake was JPMorgan Chase: 1,320 shares worth $114K.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Cognizant, an estimated $7.87M trimmed.

  • Veritas Investment Management's largest Q4 2016 buy was JPMorgan Chase: 1,320 shares worth $114K.
  • Veritas Investment Management added most to Thermo Fisher Scientific in Q4 2016, an estimated $22.6M increase.
  • Veritas Investment Management's biggest Q4 2016 reduction was Cognizant, cutting an estimated $7.87M.
  • Veritas Investment Management fully exited Varian Medical Systems, Inc. in Q4 2016, selling an estimated $831K.
  • Veritas Investment Management's ten largest holdings make up 84% of its $566M portfolio in Q4 2016.
  • Veritas Investment Management opened 10 new positions and closed 6 in Q4 2016.
  • Veritas Investment Management's portfolio value rose 6.2% quarter-over-quarter to $566M.

Based on Veritas Investment Management's 13F filing for Q4 2016, filed 31 Jan 2017.